Downregulation of microRNA -132 by DNA hypermethylation is associated with cell invasion in colorectal cancer

OncoTargets and Therapy

Volumn 8, Issue , 2015, Pages 3639-3648

  Qin, Jun ^a   Ke, Jing ^a   Xu, Junfei ^a   Wang, Feiran ^a   Zhou, Youlang ^a   Jiang, Yasu ^a   Wang, Zhiwei ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Colorectal cancer; DNA methylation; Invasion; microRNA 132

Indexed keywords

DECITABINE; MICRORNA 132; PAXILLIN;

ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER CELL LINE; CANCER INHIBITION; CANCER PROGNOSIS; CLINICAL ARTICLE; COLON; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE STUDY; RECTUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOGENESIS; TUMOR INVASION;

EID: 84949633161     PISSN: 11786930     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S91560     Document Type: Article

References (23)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60: 277-300.
2. Li HZ, Mao WM, Wang XH, Yu CD, Du LB. Incidence and mortality of cancer in Zhejiang province in 2009. Zhonghua Yu Fang Yi Xue Za Zhi. 2013; 47: 592-596.
3. Kim J, Huynh R, Abraham I, Kim E, Kumar RR. Number of lymph nodes examined and its impact on colorectal cancer staging. Am Surg. 2006; 72: 902-905.
4. Obernosterer G, Tafer H, Martinez J. Target site effects in the RNA interference and microRNA pathways. Biochem Soc Trans. 2008; 36: 1216-1219.
5. Vella MC, Reinert K, Slack FJ. Architecture of a validated microRNA: target interaction. Chem Biol. 2004; 11: 1619-1623.
6. Harfe BD. MicroRNAs in vertebrate development. Curr Opin Genet Dev. 2005; 15: 410-415.
7. Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103: 2257-2261.
8. Anand S, Majeti BK, Acevedo LM, et al. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med. 2010; 16: 909-914.
9. Zheng YB, Luo HP, Shi Q, et al. miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2. World J Gastroenterol. 2014; 20: 6515-6522.
10. Formosa A, Lena AM, Markert EK, et al. DNA methylation silences miR-132 in prostate cancer. Oncogene. 2013; 32: 127-134.
11. Zhang S, Hao J, Xie F, et al. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis. 2011; 32: 1183-1189.
12. Razin A, Riggs AD. DNA methylation and gene function. Science. 1980; 210: 604-610.
13. Chimonidou M, Strati A, Tzitzira A, et al. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clin Chem. 2011; 57: 1169-1177.
14. Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol. 2010; 42: 1273-1281.
15. Wei X, Tan C, Tang C, et al. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal. 2013; 25: 1037-1043.
16. Li S, Meng H, Zhou F, et al. MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract. 2013; 209: 179-183.
17. Miller BH, Zeier Z, Xi L, et al. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A. 2012; 109: 3125-3130.
18. Wanet AS, Tacheny A, Arnould T, Renard P. miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res. 2012; 40: 4742-4753.
19. Chen DL, Wang DS, Wu WJ, et al. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis. 2013; 34: 803-811.
20. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3: 415-428.
21. Tost J. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Mol Biotechnol. 2010; 44: 71-81.
22. Ramchandani S, Bhattacharya SK, Cervoni N, Szyf M. DNA methylation is a reversible biological signal. Proc Natl Acad Sci U S A. 1999; 96: 6107-6112.
23. Lyko F, Brown R. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst. 2005; 97: 1498-1506.